Sepsis since the discovery of Toll-like receptors: Disease concepts and therapeutic opportunities
- 1 May 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (5) , 1404-1410
- https://doi.org/10.1097/01.ccm.0000261883.16943.4b
Abstract
Sepsis and its sequelae are the leading cause of death in critically ill patients. Discovery in the late 1990s of Toll-like receptors as primary sensors of microbial infection led to significant advances in understanding the pathogenesis of sepsis, including emerging differences between Gram-positive and Gram-negative infection and the potential for the manipulation of Toll-like receptors for the treatment of sepsis. This review describes these advances. Bibliographic search of the literature since 1999, with particular emphasis on the conceptual and therapeutic implications of Toll-like receptors for patients with systemic sepsis. Toll-like receptors initiate the inflammatory processes that underlie the clinical response to infection and therefore represent an important putative target for therapeutic intervention.Keywords
This publication has 84 references indexed in Scilit:
- Septic shockPublished by Elsevier ,2005
- Peptidoglycan and Lipoteichoic Acid in Gram-Positive Bacterial Sepsis: Receptors, Signal Transduction, Biological Effects, and SynergismShock, 2003
- Current Epidemiology of Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Has the mortality of septic shock changed with time?Critical Care Medicine, 1998
- Staphylococcus aureusInfectionsNew England Journal of Medicine, 1998
- Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.American Journal of Respiratory and Critical Care Medicine, 1996
- Response of man to endotoxinImmunobiology, 1993